From: Incidence and predictive factors of diaphragmatic dysfunction in acute stroke
Age | 69.30 years ±9.66 years |
Sex | 51.7% (n = 31) male |
Arterial hypertension | 63.3% (n = 38) |
Dyslipidaemia | 46.7% (n = 28) |
Diabetes mellitus | 30% (n = 18) |
Smoking | 66.7% (n = 40) no smoking |
16.7% (n = 10) former smoker | |
COPD | 6.7% (n = 4) |
SAHS | 10% (n = 6) |
Dyspnoea | 84.7% (n = 50) Grade 0 |
10.2% (n = 6) Grade 1 | |
NYHA scale | 60% (n = 36) Class 1 |
35% (n = 21) Class 2 | |
Vascular territory affected | Small vessel 19 (31.7%) |
ACA 4 (6.66%) | |
MCA 32 (53.33%) | |
PCA 4 (6.66%) | |
Carotid 1 (1.66%) | |
NIHSS | 3 (2–6) |
Reperfusion therapies | 58.3% (n = 35) No therapy |
20% (n = 12) Thrombolysis | |
18.3% (n = 11) Thrombectomy | |
3.3% (n = 2) Both therapies |